ArticleThe Journal of experimental medicine2007

IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta.

Ari Waisman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.